GeorgeannaKlingensmithMD

Pediatric Endocrinology • Aurora, CO

Barbara Davis Center, University of Colorado

Join to view full profile

Dr. Klingensmith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Klingensmith's full profile

Already have an account?

Office
1775 Aurora Ct
Aurora, CO 80045
Phone+1 303-724-2323

Fax+1 303-724-6779

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Endocrinology, 1974 - 1976
Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1972 - 1974
University of Colorado School of MedicineInternship, Transitional Year, 1971 - 1972
Duke University School of MedicineClass of 1971

Certifications & Licensure

CO State Medical License Active through 2019
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Endocrinology

Clinical Trials

In-Clinic and Home-Use Study of a New Blood Glucose Monitoring System Start of enrollment: 2008 Dec 01
Completed
Not Applicable
Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults Start of enrollment: 2013 Nov 01
Completed
Phase 3
Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes Start of enrollment: 2013 Nov 01
Completed
Phase 2, Phase 3

Publications & Presentations

PubMed

20 citations
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO...
Lori M Laffel, Thomas Danne, Georgeanna J Klingensmith, William V Tamborlane, Steven Willi
The Lancet. Diabetes & Endocrinology. 2023-03-01
1 citations
ZnT8 autoantibody prevalence is low in youth with type 2 diabetes and associated with higher insulin sensitivity, lower insulin secretion, and lower disposition index.
Janine Higgins, Philip Zeitler, Kimberly L Drews, Silva Arslanian, Kenneth Copeland
Journal of Clinical & Translational Endocrinology. 2022-09-01
2 citations
Youth with type 2 diabetes have a high rate of treatment failure after discontinuation of insulin: A Pediatric Diabetes Consortium study.
Risa M Wolf, Peiyao Cheng, Robin L Gal, Lindsey C Beaulieu, Craig Kollman
Pediatric Diabetes. 2022-06-01

Lectures

Visit Frequency Influences HbA1c at 12 Months in Children with Type 1 Diabetes (T1D)
Aurora, CO - 6/14/2014
Feasibility and Acceptability of Shared Medical Appointments in Middle School Populations with Type 1 Diabetes
Aurora, CO - 6/15/2014

Press Mentions

Youth with Type 1 Diabetes May Suffer Health Risks When Transitioning from Pediatric to Adult CareFebruary 10th, 2016

Grant Support

Gonadotrophin Releasing Hormone Antagonist/Treatment Isosexual PrecocityNational Center For Research Resources1987–1988